Simplification of Low Level Internal Dosimetry

NCT03580161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2023-06-27

No results posted yet for this study

Summary

This is a pilot study with the primary aim being to identify the minimum number of scans and measurements necessary to determine accurately the absorbed radiation doses delivered from internal sources of radiation administered for diagnostic nuclear medicine procedures.

Conditions

  • Exposure to Medical Diagnostic Radiation

Interventions

OTHER

18-F FDG PET/CT dosimetry scans and measurements

Participants will have additional scans and retention measurements for dosimetry alongside their routine diagnostic scans

OTHER

Ga-68 PSMA PET/CT dosimetry scans and measurements

Participants will have additional scans and retention measurements for dosimetry alongside their routine diagnostic scans

OTHER

68-Ga Dotatate PET/CT dosimetry scans and measurements

Participants will have additional scans and retention measurements for dosimetry alongside their routine diagnostic scans

OTHER

99mTc Pertechnetate Thyroid dosimetry scans and measurements

Participants will have additional scans and retention measurements for dosimetry alongside their routine diagnostic scans

OTHER

99mTc DMSA(III) Renal dosimetry scans and measurements

Participants will have additional scans and retention measurements for dosimetry alongside their routine diagnostic scans

OTHER

99mTc MAG3 Renal dosimetry scans and measurements

Participants will have additional scans and retention measurements for dosimetry alongside their routine diagnostic scans

OTHER

99mTc MDP/HDP Bone dosimetry scans and measurements

Participants will have additional scans and retention measurements for dosimetry alongside their routine diagnostic scans

Sponsors & Collaborators

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Glenn Flux · Royal Marsden NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-30
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03580161 on ClinicalTrials.gov